Subject: Andrew Left

Subject of Interest

Andrew Edward Left is an activist short seller, author and editor of the online investment newsletter Citron Research, formerly StockLemon.com. Left is known for advising investors on short selling and has often appeared on various media outlets such as CNBC and Bloomberg to talk about his opinions on stocks. In 2016, Left was banned for five years by the Hong Kong Market Misconduct Tribunal for disclosing false or misleading information, and so inducing transactions under the Securities and Futures Ordinance.

Biography

Release: Andrew Left Naked Short Selling Inovio? Block & Leviton in Collusion Defaming and Committing Tortious Interference?

Release

Citron Research Further Criticizes Inovio Pharmaceuticals, Inc.; Investors Who Lost Money Should Contact Block & Leviton LLP Who Filed First Shareholder Lawsuit

Global Newswire, 27 April 2020

BOSTON, April 27, 2020 (GLOBE NEWSWIRE) — Today, research analyst Citron Research published a report calling Inovio (INO) “The COVID-19 Version of Theranos,” in which Citron slashed its target price for Inovio common stock by 93%.

Dr Left has a $1 target stock is $11 ( you know he shorted at $16-17 and covered already never waiting for his $1 target   SHORT AND DISTORT  for a quick profit

Continue reading “Release: Andrew Left Naked Short Selling Inovio? Block & Leviton in Collusion Defaming and Committing Tortious Interference?”

Article: One of Wall Street’s most notorious short-sellers says Peloton will plummet 86%, citing ‘intense’ competition (PTON)

Article - Media

One of Wall Street’s most notorious short-sellers says Peloton will plummet 86%, citing ‘intense’ competition (PTON)

Carmen Reinicke

MarketInsider, 10 December 2019

 

  • Citron Research, run by the famed short-seller Andrew Left, slapped Peloton with a $5 price target on Tuesday.
  • That would imply an 86% drop from Monday’s close of $34.77.
  • Citron argued that the losses would come amid “intense” competition that’s mounting.
  • Shares of Peloton fell as much as 9.1% on Tuesday.

Comment:  Yelling fire in a crowded theatre is a crime A short and distort SELL REPORT How about selling his sell tickets IS he still short? his target is $5 right I bet he covered 10 min after his report . Andrew Left should be under investigation. His recommendations should be compared to his positions.

 

Article: Citron’s Andrew Left slams Jumia as a ‘fraud,’ accuses company of ‘financial colonialism’ in latest video

Article - Media

Citron’s Andrew Left slams Jumia as a ‘fraud,’ accuses company of ‘financial colonialism’ in latest video

Tonya Garcia

MarketWatch, 29 May 2019

Citron Research’s Andrew Left, a noted short seller, is once again slamming Jumia Technologies AG as a “fraud,” this time in a video that includes footage of what he says are former employees who accuse the company of placing fake orders.

Comment:  Down from $36 to $3 based on a naked short selling campaign apparently led by Andrew Left.

Article: Shopify dives after short-seller Andrew Left of Citron Research shorts the e-commerce stock

Article - Media

Shopify dives after short-seller Andrew Left of Citron Research shorts the e-commerce stock

Ellen Kelleher

Proactive Investors, 4 April 2019

Citron’s short position stems from a ‘perfect storm’ of business setbacks that will knock Shopify ‘off its high wire to $100 in the next 12 months’

Shares of Shopify Inc (NYSE:SHOP) tumbled Thursday after famed short-seller Andrew Left of Citron Research went bearish and urged investors to short the Canadian e-commerce company.

In a research note, Left and his team make the case that their newly-adopted short position stems from a “perfect storm” of business setbacks that will knock Shopify “off its high wire to $100 in the next 12 months.”

Continue reading “Article: Shopify dives after short-seller Andrew Left of Citron Research shorts the e-commerce stock”

Article: Short-seller Andrew Left to appeal against Hong Kong market ban

Article - Media

Short-seller Andrew Left to appeal against Hong Kong market ban

Reuters, 26 February 2019

HONG KONG (Reuters) – U.S. short seller Andrew Left lost his legal bid on Tuesday to overturn a five-year ban from Hong Kong’s financial markets and a fine for market manipulation.

Left, founder of U.S.-based short-seller Citron Research, was banned in 2016 after he was found culpable of market misconduct in connection with the publication of a research report on Chinese property developer China Evergrande Group.

Article: Citron Research “Exposes” Exact Sciences – Short Term Target $20

Article - Media

Citron Research “Exposes” Exact Sciences – Short Term Target $20

Guest

ValueWalk.com, 15 May 2017

Citron Research exposes Exact Sciences and PROVES beyond ANY doubt why this stock will soon be cut in half  – so says a new reprot from Citron Research – Citron founder Andrew Left  battled the CEO of Exact on CNBC on that topic for CNBC pro sub subscribers you can find that video here

Comment:  Knocked stock down from $30 to $22. They needed to cover, stock then went to $125.